COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,003 Articles (22,627 medRxiv, 8,376 bioRxiv)

Most recent first Previous |  Page 114: Articles 1131-1140  | Next

Genomic characterization of a persistent, azole-resistant C. parapsilosis strain responsible for a hospital outbreak during the first COVID-19 wave
Vumbaca, M., Batisti Biffignandi, G., Cavanna, C., Belllinzona, G., Corbella, M., Cambieri, P., Rhodes, J., Corander, J., Baldanti, F., Sassera, D.
10.1101/2024.11.11.622614 — Posted: 2024-11-12
Cost-effectiveness of routine COVID-19 adult vaccination programmes in England
Keeling, M. J., Hill, E. M., Petrou, S., Bich Tran, P., Png, M. E., Staniszewska, S., Clark, C., Hassel, K., Stowe, J., Andrews, N.
10.1101/2024.11.08.24316972 — Posted: 2024-11-12
Implementation and results of active vaccine safety monitoring during the COVID-19 pandemic in the UK
Wong, J., Donegan, K., Harrison, K., Jan, T., Cave, A., Tregunno, P.
10.1101/2024.11.06.24316782 — Posted: 2024-11-12
Vaccine-induced and hybrid immunity against SARS-CoV-2 variants of concern in two cohorts in Queensland, Australia (2021-2022).
Parry, R. H., Shang, Y. H., Sng, J. D. J., McMillan, C. L. D., Modhiran, N., Amarilla, A. A., Isaacs, A., Liang, B., Muller, D. A., Rawle, D. J., Suhrbier, A., Anderson, S., Kelly, S., Watterson, D., Burr, L., Khromykh, A.
10.1101/2024.11.11.623100 — Posted: 2024-11-12
The Virtual Lab: AI Agents Design New SARS-CoV-2 Nanobodies with Experimental Validation
Swanson, K., Wu, W., Bulaong, N. L., Pak, J. E., Zou, J.
10.1101/2024.11.11.623004 — Posted: 2024-11-12
Wastewater sequencing from a rural community enables identification of widespread adaptive mutations in a SARS-CoV-2 Alpha variant
Conway, M. J., Novay, M. P., Pusch, C. M., Ward, A. S., Abel, J. D., Williams, M. R., Uzarski, R. L., Alm, E. W.
10.1101/2024.11.11.24316360 — Posted: 2024-11-11
Socioeconomic and temporal heterogeneity in SARS-CoV-2 exposure and disease in England from May 2020 to February 2023
Morgenstern, C., Rawson, T., Hinsley, W., Perez-Guzman, P. N., Bhatt, S., Ferguson, N. M.
10.1101/2024.11.11.24317098 — Posted: 2024-11-11
Impact of chronic pain on numerous long COVID-like symptoms: A large-scale internet-based epidemiological study in Japan
Takaoka, S., Saito, H., Kawate, M., Tanaka, C., Wu, Y., Kosugi, S., Yamada, T., Tabuchi, T., Wakaizumi, K.
10.1101/2024.11.11.24317094 — Posted: 2024-11-11
A Mouse-adapted SARS-CoV-2 Model for Investigating Post-acute Sequelae of COVID infection
Zhao, Z., Qiao, H., Qu, Y., Qiu, L., Chiu, Y., He, X., Ge, T., Yuan, W.
10.1101/2024.11.10.622868 — Posted: 2024-11-11
Preprints vs. Journal Articles: Citation Impact in COVID-19 Research
Tsunoda, H., Sun, Y., Nishizawa, M., Liu, X., Amano, K., Kominami, R.
10.1101/2024.11.08.622753 — Posted: 2024-11-11

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).